Instead, the transcripts of AR v567es and AR-V7 (trending toward significance) were upregulated in enzalutamide-resistant tumors, while the levels of AR-V4 or AR-FL transcript did not differ (Figure 6A - D ).
← all excerpts
Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy.
1
—
—